$SOBI #Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum - Challenges persist - down to HOLD: Sobi sees gout market as an opportunity We spoke to KOLs in ITP regarding Doptelet Time to take a breather – down to HOLD (Buy) https://t.co/GETAs8F2aC #equity #stocks https://t.co/9kQJ11GxrJ